Corrigendum: Histone Deacetylase 3 Aggravates Type 1 Diabetes Mellitus by Inhibiting Lymphocyte Apoptosis Through the microRNA-296-5p/Bcl-xl Axis

Qibo Hu,Guanghua Che,Yu Yang,Hongchang Xie,Jing Tian

DOI: https://doi.org/10.3389/fgene.2021.715061

IF: 3.7

2021-09-22

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2020.536854.].

genetics & heredity

What problem does this paper attempt to address?

Corrigendum: Adiponectin Modified BMSCs Alleviate Heart Fibrosis Via Inhibition TGF-beta1/smad in Diabetic Rats

Ke Meng,Huacong Cai,Simin Cai,Yucai Hong,X Zhang

DOI: https://doi.org/10.3389/fcell.2023.997572

IF: 5.5

2023-01-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.644160.].
Corrigendum: MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy

Hong Zhou,Wei-Jian Ni,Xiao-Ming Meng,Li-Qin Tang

DOI: https://doi.org/10.3389/fcell.2022.875280

IF: 5.5

2022-03-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2020.618536.].

cell biology,developmental biology
Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Feng Shi,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].
Correction to “gut Microbiota Dysbiosis in Chinese Children with Type 1 Diabetes Mellitus: an Observational Study”

Xia Liu,Yi-Wen Cheng,Li Shao,Shu-Hong Sun,Jian Wu,Qing-Hai Song,Hong-Sheng Zou,Zong-Xin Ling

DOI: https://doi.org/10.3748/wjg.v28.i25.3006

IF: 5.374

2022-01-01

World Journal of Gastroenterology

Abstract:[This corrects the article on p. 2394 in vol. 27, PMID: 34040330.].
Corrigendum: Role of TGF-β/Smad Pathway in the Transcription of Pancreas-Specific Genes During Beta Cell Differentiation

Yuhua Gao,Ranxi Zhang,Shanshan Dai,Xue Zhang,Xiangchen Li,Chunyu Bai

DOI: https://doi.org/10.3389/fcell.2020.614840

IF: 5.5

2020-11-06

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2019.00351.].

cell biology,developmental biology
Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Pingping Ren,Luying Lu,Shasha Cai,Jianghua Chen,Weiqiang Lin,Fei Han

DOI: https://doi.org/10.3389/fimmu.2024.1513491

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.713540.].
Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Wan-Xin Peng,Fei Liu,Jia-Hong Jiang,Hang Yuan,Ziqiang Zhang,Liu Yang,Yin-Yuan Mo

DOI: https://doi.org/10.1016/j.gendis.2024.101352

2024-06-15

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.014.].
Corrigendum: Hyperglycemia decreases epithelial cell proliferation and attenuates neutrophil activity by reducing ICAM-1 and LFA-1 expression levels

Dongxu Qiu,Lei Zhang,Junkun Zhan,Qiong Yang,Hongliang Xiong,Weitong Hu,Qiao Ji,Jiabing Huang

DOI: https://doi.org/10.3389/fgene.2024.1431933

IF: 3.7

2024-07-18

Frontiers in Genetics

Abstract:This article is a correction to: Hyperglycemia Decreases Epithelial Cell Proliferation and Attenuates Neutrophil Activity by Reducing ICAM-1 and LFA-1 Expression Levels

genetics & heredity
Corrigendum: C1q/TNF-Related Protein 9 Attenuates Atherosclerosis by Inhibiting Hyperglycemia-Induced Endothelial Cell Senescence Through the AMPKα/KLF4 Signaling Pathway

Gang Wang,Baihe Han,Ruoxi Zhang,Qi Liu,Xuedong Wang,Xingtao Huang,Dandan Liu,Weishen Qiao,Mengyue Yang,Xing Luo,Jingbo Hou,Bo Yu

DOI: https://doi.org/10.3389/fphar.2021.812384

IF: 5.6

2021-12-15

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.758792.].

pharmacology & pharmacy
Corrigendum: ASK1-interacting protein 1 acts as a novel predictor of type 2 diabetes.

Zhigao Song,Cong Chen,Jipei He,Bixia Liu,Weidong Ji,Liangping Wu,Li He

DOI: https://doi.org/10.3389/fendo.2022.981231

IF: 6.055

2022-01-01

Frontiers in Endocrinology

Abstract:[This corrects the article DOI: 10.3389/fendo.2022.896753.].
Corrigendum: Blood Immune Cell Composition Associated With Obesity and Drug Repositioning Revealed by Epigenetic and Transcriptomic Conjoint Analysis

Jia-Chen Liu,Sheng-Hua Liu,Guang Fu,Xiao-Rui Qiu,Run-Dong Jiang,Sheng-Yuan Huang,Li-Yong Zhu,Wei-Zheng Li

DOI: https://doi.org/10.3389/fphar.2021.838902

IF: 5.6

2022-01-10

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.714643.].

pharmacology & pharmacy
Corrigendum to "TERT and Akt Are Involved in the Par-4-Dependent Apoptosis of Islet β Cells in Type 2 Diabetes".

Chen Liu,Wu QiNan,Lei XiaoTian,Yang MengLiu,Gan XiaGuang,Leng WeiLing,Liang ZiWen,Zhang Ling,Yang GangYi,Chen Bing

DOI: https://doi.org/10.1155/2020/1912058

IF: 4.0608

2020-01-01

Journal of Diabetes Research

Abstract:[This corrects the article DOI: 10.1155/2018/7653904.].
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Corrigendum: Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program.

Feng Xu,Yanhua Kang,Ningtong Zhuang,Zhe Lu,Hang Zhang,Dakang Xu,Yina Ding,Hongping Yin,Liyun Shi

DOI: https://doi.org/10.1038/srep46904

IF: 4.6

2017-01-01

Scientific Reports

Abstract:This corrects the article DOI: 10.1038/srep18778.
Corrigendum: Ginsenoside Rg1 ameliorates neuroinflammation via suppression of connexin43 ubiquitination to attenuate depression

Huiqin Wang,Yantao Yang,Songwei Yang,Siyu Ren,Juling Feng,Yangbo Liu,Haodong Chen,Naihong Chen

DOI: https://doi.org/10.3389/fphar.2024.1418824

2024-07-17

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.709019.].
Corrigendum: Ginsenoside Re Attenuates High Glucose-Induced RF/6A Injury via Regulating PI3K/AKT Inhibited HIF-1a/VEGF Signaling Pathway

Weijie Xie,Ping Zhou,Muwen Qu,Ziru Dai,Xuelian Zhang,Chenyang Zhang,Xi Dong,Guibo Sun,Xiaobo Sun

DOI: https://doi.org/10.3389/fphar.2020.01312

2020-10-23

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.00695.].
Corrigendum to “Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus”

Ruiqi Tang,Lanjuan Li

DOI: https://doi.org/10.1155/2021/9756586

2021-06-04

Canadian Journal of Infectious Diseases and Medical Microbiology

Abstract:[This corrects the article DOI: 10.1155/2021/6632266.].

infectious diseases,microbiology
Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation

Qiang Wang,Yuemei Xi,Binyang Chen,Hairong Zhao,Wei Yu,De Xie,Weidong Liu,Furong He,Chenxi Xu,Jidong Cheng

DOI: https://doi.org/10.3389/fphar.2022.1022539

IF: 5.6

2022-11-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.907133.].

pharmacology & pharmacy
Corrigendum: LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease via Skewing Allogeneic T Cells Polarization Towards Treg Cells

Huihui Liu,Zhengyu Yu,Bo Tang,Shengchao Miao,Chenchen Qin,Yuan Li,Zeyin Liang,Yongjin Shi,Yang Zhang,Qingya Wang,Miao Yan,Zhengyang Song,Hanyun Ren,Yujun Dong

DOI: https://doi.org/10.3389/fimmu.2021.762728

2021-09-16

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.647894.].
Corrigendum: Ginsenoside compound K attenuates ox-LDL-mediated macrophage inflammation and foam cell formation via autophagy induction and modulating NF-kB, p38, and JNK MAPK signaling

Shan Lu,Yun Luo,GuiBo Sun,XiaoBo Sun

DOI: https://doi.org/10.3389/fphar.2024.1452605

2024-07-23

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.567238.].

Corrigendum: Histone Deacetylase 3 Aggravates Type 1 Diabetes Mellitus by Inhibiting Lymphocyte Apoptosis Through the microRNA-296-5p/Bcl-xl Axis

Corrigendum: Adiponectin Modified BMSCs Alleviate Heart Fibrosis Via Inhibition TGF-beta1/smad in Diabetic Rats

Corrigendum: MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes &amp; Diseases 9(2022) 443–455]

Correction to “gut Microbiota Dysbiosis in Chinese Children with Type 1 Diabetes Mellitus: an Observational Study”

Corrigendum: Role of TGF-β/Smad Pathway in the Transcription of Pancreas-Specific Genes During Beta Cell Differentiation

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Corrigendum: Hyperglycemia decreases epithelial cell proliferation and attenuates neutrophil activity by reducing ICAM-1 and LFA-1 expression levels

Corrigendum: C1q/TNF-Related Protein 9 Attenuates Atherosclerosis by Inhibiting Hyperglycemia-Induced Endothelial Cell Senescence Through the AMPKα/KLF4 Signaling Pathway

Corrigendum: ASK1-interacting protein 1 acts as a novel predictor of type 2 diabetes.

Corrigendum: Blood Immune Cell Composition Associated With Obesity and Drug Repositioning Revealed by Epigenetic and Transcriptomic Conjoint Analysis

Corrigendum to "TERT and Akt Are Involved in the Par-4-Dependent Apoptosis of Islet β Cells in Type 2 Diabetes".

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Corrigendum: Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program.

Corrigendum: Ginsenoside Rg1 ameliorates neuroinflammation via suppression of connexin43 ubiquitination to attenuate depression

Corrigendum: Ginsenoside Re Attenuates High Glucose-Induced RF/6A Injury via Regulating PI3K/AKT Inhibited HIF-1a/VEGF Signaling Pathway

Corrigendum to “Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus”

Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation

Corrigendum: LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease via Skewing Allogeneic T Cells Polarization Towards Treg Cells

Corrigendum: Ginsenoside compound K attenuates ox-LDL-mediated macrophage inflammation and foam cell formation via autophagy induction and modulating NF-kB, p38, and JNK MAPK signaling

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]